Amikacin
Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
---|---|---|---|
Antibiotics | Amikacin | LD 5-7.5mg/kg IV, then 5mg/kg IV QHD | Administer Post-HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
---|---|---|---|---|---|---|---|
586 | 95 | 1.4-2.3 | 17-150 | <5 | 0.22-0.29 | 21.5-125.6 | 18.5-88 (low flux) |
References:
- Armstrong D, Hodgman T, Visconti J, et al. Hemodialysis of amikacin in critically ill patients. Critical Care Medicine 1988; 16(5), 517-521.
- Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00479
- Heintz B, Matzke G, Dager W. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009; 29(5), 562-77.
- Kihara M, Ikeda Y, Takagi N, et al. Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis. Intensive care medicine 1995; 21(4), 348-51.
- Launay-Vacher V, Izzedine H, Deray G. Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. Clinical pharmacokinetics 2005; 44(3), 221-35.
- Madhavan T, Yaremchuk K, Levin N et al. Effect of Renal Failure and Dialysis on the Serum Concentration of the Aminoglycoside Amikacin. Antimicrobial agents and chemotherapy 1976; 10(3), 10-13.
- Matzke G. Status of Hemodialysis of Drugs in 2002. Journal of Pharmacy Practice 2002; 15(5), 405-418.
- Plantier J, Forrey A, Neill M et al. Pharmacokinetics of Amikacin in Patients with Normal or Impaired Renal Function : Radioenzymatic Acetylation Assay. Journal of Infectious Diseases 1976; 134(Supplement), 323-330.
- Regeur L, Colding H, Kampmann J, Jensen H. Pharmacokinetics of Amikacin During Hemodialysis and Peritoneal Dialysis. Antimicrobial agents and chemotherapy 1977; 11(2), 214-8.
- Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infectious Disease Clinics of North America 2003; 17(3), 503-528.